|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
AMINOGLYCOSIDES NEUROTOXICITY CAN RESULT IN RESPIRATORY PARALYSIS DUE TO NEUROMUSCULAR BLOCKADE ESPECIALLY WHEN DRUS IS GIVEN SOON AFTER THE USE OF ANAESTHESIA OR MUSCLE RELAXANTS
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
|
|
|
|
|
|
|
|
|
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
AMINOGLYCOSIDES LIKE DRUGS OTOTOXICITY MAY BE MASKED BY THE DRUG
|
INCREASED RISK OF NEPHROTOXICITY
|
|
|
|
|
|
|
|
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|